Rob Wright - Chief Editor

Rob Wright

Rob Wright

Rob Wright is the chief editor of Life Science Leader magazine. Prior to joining the publication, he spent nearly 20 years in the pharmaceutical industry. During his industry career, Wright conducted well over 1,000 presentations and roundtable discussions, including the facilitation of FDA-mandated clinical training programs for hundreds of licensed healthcare providers. He has chaired, co-chaired, moderated, and served as a speaker at industry and academic conferences and is the past co-chair for the 2015 BIO International conference educational planning committee. Wright’s 100+ published articles have appeared in peer-reviewed academic journals, B2B magazines and online publications. He received a B.S. in Business Administration from Indiana University of Pennsylvania, MBA with distinction from Gannon University, and completed his doctoral coursework in marketing at Cleveland State University. He is a member of international business honor societies Sigma Beta Delta and Beta Gamma Sigma.

ROB'S WORK

What Is BIO’s Focus For 2017 And Beyond? More Buzz From BIO CEO

Hosting the BIO Buzz Center during the 2017 BIO CEO & Investor Conference in New York City on behalf of Life Science Leader magazine provided me the opportunity to conduct five video interviews with a number of industry executives and thought leaders.

From Hospital Research Project To Spark Therapeutics – Just One Of The Companies Creating Buzz At BIO CEO 2017

As host of the BIO Buzz Center during the 2017 BIO CEO & Investor Conference in New York City, Life Science Leader magazine conducted five video interviews with a number of industry executives and thought leaders.

Myovant Sciences CEO Creates Buzz At 2017 BIO CEO & Investor Conference

As host of the BIO Buzz Center during the 2017 BIO CEO & Investor Conference in New York City, Life Science Leader magazine had the opportunity to conduct five video interviews with a number of industry executives and thought leaders.

Reader Engagement Helps Us Fulfill Our Mission … And Feel Good, Too

A few years ago I met Mark Scharenbroich. Thankfully, the award-winning author of Nice Bike — Making Meaningful Connections on the Road of Life ended up contributing a Leadership Lessons article for Life Science Leader magazine.

CSL Limited CEO Shares Insights Beyond Just How To Grow Revenue

Being the head of any Big Pharma is bound to test an executive’s work-life balance. But when that Big Pharma is headquartered in Australia, and the company prides itself on being a “global operation,” maintaining any kind of work-life balance is a formidable task. “I’m not the poster child for how to strive for work-life balance,” admits Paul Perreault, CEO and managing director of CSL.

The Secrets To CSL Limited’s Incredible Revenue Growth

CSL Limited’s CEO Paul Perreault gives us a behind-the-scenes look at how the company increased revenue by 33% while also increasing R&D by 73% and capital investment by 83%.

What JPM 2017 Revealed To Me

As I walked into a breakout session on at JPM, I couldn’t help but overhear people discussing the latest negative news to hit the biopharma industry.

Leadership Lessons From Chris Ruisi — Author Of "Step Up And Play Big"

We’ve all probably encountered the frustrations related to flight delays and cancellations. I recently experienced the latter while on my way to the 35th Annual J. P. Morgan Healthcare Conference (commonly referred to as JPM) in San Francisco. Although, one positive did come out of my unplanned delay — it afforded me the opportunity to get through a leadership book I had been meaning to read, Step Up And Play Big by Chris Ruisi.

Despite Delays, JPM 2017 Still Pays Off For Me

For the second year in a row my travel plans to the biopharmaceutical industry’s yearly kickoff event — the 35th Annual J. P. Morgan Healthcare Conference in San Francisco —was disrupted by weather. And though I once again arrived a day late, there was still plenty to keep me busy during JPM. For example, I still had the opportunity to sit in breakout Q&A sessions involving Alkermes, BMS, Chimerix, GSK, Mylan NV, and Shire. I witnessed company presentations that included AbbVie, CSL Limited, and IDEXX (just to name a few). I attended keynotes involving the Vice President of the United States, Joe Biden, who provided an update on the Cancer Moonshot initiative. I heard political consultants Karl Rove and James Carville debate the pros and cons of repealing and replacing the Affordable Care Act. I even had the opportunity to hear Juan Enriquez, co-author of Evolving Ourselves, share his insights on the next species of human. And while this may seem like a lot, it really only scratches the surface as to the amount of activity that takes place during JPM in January.